LMAT logo

LeMaitre Vascular, Inc. (LMAT)

Profile

Full Name

LeMaitre Vascular, Inc.

Ticker

NASDAQ: LMAT

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

October 19, 2006

Indexes

Not included

Website

https://www.lemaitre.com

Employees

651

Key Details

Price

$92.45(+0.09%)

Market cap

$2.09B(Mid cap)

Last Dividend

$0.20

TTM Dividend yield

0.82%

Annual revenue

$219.86M(+13.63% YoY)

Annual EPS

$1.93(+44.03% YoY)

PE ratio

44.88

Next earnings date

Oct 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $92.45
    LMAT price is $92.45

    30-Day Relative Volume

    0.76
    LMAT 30-day relative volume is 0.76

    Price Performance

    Price Most recent change

    +0.09%
    LMAT price was up +0.09% on Sep 16, 2025

    Price YTD change

    +0.34%
    LMAT price is up +0.34% since January 1st

    Price 1-year change

    +4.09%
    LMAT price is up +4.09% year-on-year

    Price 3-year change

    +86.99%
    LMAT price is up +86.99% over the past 3 years

    Price Range

    Price All-time high

    $109.58
    LMAT price is currently -15.63% below its historical high of $109.58

    Price 3-year low

    $41.78
    LMAT price is currently +121.28% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.09B
    LMAT market capitalization is $2.09 billion

    Market cap 3-year change

    +92.74%
    LMAT market capitalization is up +92.74% over the past 3 years

    Market cap All-time high

    $2.43B
    LMAT market capitalization is currently -13.79% below its historical high of $2.43 billion

    Market cap sector rank

    81.29%
    LMAT market capitalization is higher than 81.29% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.75%
    LMAT shares outstanding is up +0.75% year-on-year

    Shares Outstanding 3-Year Change

    +3.07%
    LMAT shares outstanding is up +3.07% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.73
    LMAT beta is 0.73

    200-day SMA

    $89.69
    LMAT price is currently +3.07% above its 200-day simple moving average

    50-day SMA

    $89.82
    LMAT price is currently +2.93% above its 50-day simple moving average

    RSI

    46.88
    LMAT 14-day relative strength index is 46.88

    Volume

    0.76
    LMAT 30-day relative volume is 0.76

    ATR

    $2.70
    LMAT average true range is $2.70

    10-day Historical Volatility

    27.05%
    LMAT 10-day historical volatility is 27.05%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.20
    LMAT last dividend was $0.20 per share, with an ex-dividend date of August 21, 2025

    Next Dividend

    -
    LMAT next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $0.64
    LMAT annual dividend per share is $0.64

    Dividend per share Sector Rank

    26.74%
    LMAT annual dividend per share is higher than 26.74% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +14.29%
    LMAT annual dividend per share is up +14.29% year-on-year

    Dividend per share 3-Year Change

    +45.45%
    LMAT annual dividend per share is up +45.45% over the past 3 years

    Dividend yield

    Dividend yield

    0.69%
    LMAT annual dividend yield is 0.69%

    Dividend yield Sector Rank

    23.26%
    LMAT annual dividend yield is higher than 23.26% of companies in Healthcare sector

    Other

    Payout ratio

    -32.65%
    LMAT annual payout ratio is -32.65%

    Dividends paid

    -$14.38M
    LMAT annual dividends paid is -$14.38 million

    Free cash flow

    $37.16M
    LMAT annual free cash flow is $37.16 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $219.86M
    LMAT annual revenue is $219.86 million

    Revenue Analysts estimate

    $250.72M
    LMAT annual revenue is currently -12.31% lower than the consensus analysts' forecast

    Revenue 1-year change

    +13.63%
    LMAT annual revenue is up +13.63% year-on-year

    Revenue Sector rank

    74.96%
    LMAT annual revenue is higher than 74.96% of companies in Healthcare sector

    EPS

    EPS

    $1.93
    LMAT annual earnings per share is $1.93

    EPS Analysts estimate

    $2.28
    LMAT annual earnings per share is currently -15.31% lower than the consensus analysts' forecast

    EPS 1-year change

    +44.03%
    LMAT annual earnings per share is up +44.03% year-on-year

    EPS Sector rank

    91.86%
    LMAT annual earnings per share is higher than 91.86% of companies in Healthcare sector

    Profit

    Gross profit

    $145.12M
    LMAT annual gross profit is $145.12 million

    Gross margin

    66.00%
    LMAT annual gross profit margin is 66.00%

    Operating profit

    $52.26M
    LMAT annual operating income is $52.26 million

    Operating margin

    23.83%
    LMAT annual operating profit margin is 23.83%

    Net income

    $44.04M
    LMAT annual net profit is $44.04 million

    Net margin

    20.03%
    LMAT annual net profit margin is 20.03%

    Expenses

    Total expenses

    $175.82M
    LMAT annual total expenses is $175.82 million

    Operating expenses

    $92.73M
    LMAT annual total operating expenses is $92.73 million

    Cost of goods sold

    $74.75M
    LMAT annual cost of goods sold is $74.75 million

    Selling, general & administrative expenses

    $0.00
    LMAT annual SGA is $0.00

    Depreciation and amortization

    $9.67M
    LMAT annual depreciation & amortization is $9.67 million

    Interest expense

    $0.00
    LMAT annual interest expense is $0.00

    Income tax

    $12.84M
    LMAT annual income tax is $12.84 million

    EBIT & EBITDA

    EBIT

    $57.08M
    LMAT annual earnings before interest & taxes is $57.08 million

    EBITDA

    $66.75M
    LMAT annual EBITDA is $66.75 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $551.82M
    LMAT annual total assets is $551.82 million

    Non current assets

    $149.63M
    LMAT annual long term assets is $149.63 million

    Current assets

    $393.21M
    LMAT annual total current assets is $393.21 million

    Cash and cash equivalents

    $299.72M
    LMAT annual cash & cash equivalents is $299.72 million

    Accounts receivable

    $30.06M
    LMAT annual accounts receivable is $30.06 million

    Inventory

    $55.94M
    LMAT annual inventory is $55.94 million

    Liabilities

    Total liabilities

    $214.53M
    LMAT annual total liabilities is $214.53 million

    Long term liabilities

    $916.00K
    LMAT annual total long term liabilities is $916.00 thousand

    Current liabilities

    $30.61M
    LMAT annual total current liabilities is $30.61 million

    Accounts payable

    $1.76M
    LMAT annual accounts payable is $1.76 million

    Debt

    Total debt

    $185.69M
    LMAT annual total debt is $185.69 million

    Total debt 1-year change

    +872.43%
    LMAT annual total debt is up +872.43% year-on-year

    Long term debt

    $183.00M
    LMAT annual long term debt is $183.00 million

    Short term debt

    $2.68M
    LMAT annual short term debt is $2.68 million

    Equity & Capital

    Shareholders equity

    $337.29M
    LMAT annual stockholders equity is $337.29 million

    Book value

    $337.29M
    LMAT annual book value is $337.29 million

    Retained earnings

    $145.09M
    LMAT annual retained earnings is $145.09 million

    Working capital

    $362.60M
    LMAT annual working capital is $362.60 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $44.12M
    LMAT annual cash flow from operations is $44.12 million

    Cash from operations 1-year change

    +20.06%
    LMAT annual cash flow from operations is up +20.06% year-on-year

    Cash from investing

    -$200.12M
    LMAT annual cash flow from investing activities is -$200.12 million

    Cash from investing 1-year change

    -709.71%
    LMAT annual cash flow from investing activities is down -709.71% year-on-year

    Cash from financing

    $158.10M
    LMAT annual cash flow from financing activities is $158.10 million

    Cash from financing 1-year change

    +2317.11%
    LMAT annual cash flow from financing activities is up +2317.11% year-on-year

    CAPEX

    CAPEX

    $6.96M
    LMAT annual capital expenditures is $6.96 million

    CAPEX 1-year change

    -4.17%
    LMAT annual capital expenditures is down -4.17% year-on-year

    Free Cash Flow

    Free cash flow

    $37.16M
    LMAT annual free cash flow is $37.16 million

    Free cash flow 1-year change

    +26.03%
    LMAT annual free cash flow is up +26.03% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    66.00%
    LMAT annual gross profit margin is 66.00%

    Operating margin

    23.83%
    LMAT annual operating profit margin is 23.83%

    Net margin

    20.03%
    LMAT annual net profit margin is 20.03%

    ROA & ROE

    ROA

    9.80%
    LMAT annual return on assets is 9.80%

    ROE

    13.87%
    LMAT annual return on equity is 13.87%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    44.88
    LMAT price to earnings ratio is 44.88

    PE ratio Sector rank

    75.36%
    LMAT price to earnings ratio is higher than 75.36% of companies in Healthcare sector

    PB Ratio

    PB ratio

    5.77
    LMAT price to book ratio is 5.77

    PB ratio Sector rank

    81.16%
    LMAT price to book ratio is higher than 81.16% of companies in Healthcare sector

    PS Ratio

    PS ratio

    8.92
    LMAT price to sales ratio is 8.92

    PS ratio Sector rank

    71.41%
    LMAT price to sales ratio is higher than 71.41% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.96B
    LMAT enterprise value is $1.96 billion

    Enterprise value Sector rank

    80.2%
    LMAT enterprise value is higher than 80.2% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    30.20
    LMAT EV/EBITDA is 30.20

    EV/EBITDA Sector rank

    93.99%
    LMAT EV/EBITDA is higher than 93.99% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    12.85
    LMAT annual current ratio is 12.85

    Quick ratio

    11.02
    LMAT annual quick ratio is 11.02

    Leverage

    Debt to equity

    0.55
    LMAT annual debt to equity ratio is 0.55

    Interest coverage ratio

    -
    LMAT annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    6
    LMAT piotroski f-score is 6

    Altman Z-Score

    7.75
    LMAT altman z-score is 7.75

    Analyst ratings

    Recent major analysts updates

    Aug 6, 25 Cantor Fitzgerald
    Neutral
    Aug 6, 25 Barrington Research
    Outperform
    Jul 22, 25 Barrington Research
    Market Perform
    Feb 28, 25 Lake Street
    Buy
    Feb 28, 25 Citizens Capital Markets
    Buy
    Feb 28, 25 Barrington Research
    Market Perform
    Feb 13, 25 Wells Fargo
    Equal-Weight
    Nov 1, 24 Oppenheimer
    Outperform
    Nov 1, 24 Barrington Research
    Outperform
    Oct 15, 24 Cantor Fitzgerald
    Neutral

    Institutional Ownership

    Screeners with LMAT included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    • What is the ticker symbol for LeMaitre Vascular, Inc.?
    • Does LeMaitre Vascular, Inc. pay dividends?
    • What sector is LeMaitre Vascular, Inc. in?
    • What industry is LeMaitre Vascular, Inc. in?
    • What country is LeMaitre Vascular, Inc. based in?
    • When did LeMaitre Vascular, Inc. go public?
    • Is LeMaitre Vascular, Inc. in the S&P 500?
    • Is LeMaitre Vascular, Inc. in the NASDAQ 100?
    • Is LeMaitre Vascular, Inc. in the Dow Jones?
    • When was LeMaitre Vascular, Inc.'s last earnings report?
    • When does LeMaitre Vascular, Inc. report earnings?

    What is the ticker symbol for LeMaitre Vascular, Inc.?

    The ticker symbol for LeMaitre Vascular, Inc. is NASDAQ:LMAT

    Does LeMaitre Vascular, Inc. pay dividends?

    Yes, LeMaitre Vascular, Inc. pays dividends. The last payment was $0.20, with an ex-dividend date on August 21, 2025

    What sector is LeMaitre Vascular, Inc. in?

    LeMaitre Vascular, Inc. is in the Healthcare sector

    What industry is LeMaitre Vascular, Inc. in?

    LeMaitre Vascular, Inc. is in the Medical Instruments & Supplies industry

    What country is LeMaitre Vascular, Inc. based in?

    LeMaitre Vascular, Inc. is headquartered in United States

    When did LeMaitre Vascular, Inc. go public?

    LeMaitre Vascular, Inc.'s initial public offering (IPO) was on October 19, 2006

    Is LeMaitre Vascular, Inc. in the S&P 500?

    No, LeMaitre Vascular, Inc. is not included in the S&P 500 index

    Is LeMaitre Vascular, Inc. in the NASDAQ 100?

    No, LeMaitre Vascular, Inc. is not included in the NASDAQ 100 index

    Is LeMaitre Vascular, Inc. in the Dow Jones?

    No, LeMaitre Vascular, Inc. is not included in the Dow Jones index

    When was LeMaitre Vascular, Inc.'s last earnings report?

    LeMaitre Vascular, Inc.'s most recent earnings report was on August 5, 2025

    When does LeMaitre Vascular, Inc. report earnings?

    The next expected earnings date for LeMaitre Vascular, Inc. is October 30, 2025
    On this page